1. Home
  2. DNOW vs ANIP Comparison

DNOW vs ANIP Comparison

Compare DNOW & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNOW
  • ANIP
  • Stock Information
  • Founded
  • DNOW 1862
  • ANIP 2001
  • Country
  • DNOW United States
  • ANIP United States
  • Employees
  • DNOW N/A
  • ANIP N/A
  • Industry
  • DNOW Metal Fabrications
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • DNOW Industrials
  • ANIP Health Care
  • Exchange
  • DNOW Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • DNOW 1.8B
  • ANIP 1.5B
  • IPO Year
  • DNOW N/A
  • ANIP N/A
  • Fundamental
  • Price
  • DNOW $14.61
  • ANIP $66.30
  • Analyst Decision
  • DNOW Buy
  • ANIP Strong Buy
  • Analyst Count
  • DNOW 2
  • ANIP 8
  • Target Price
  • DNOW $17.50
  • ANIP $80.13
  • AVG Volume (30 Days)
  • DNOW 1.1M
  • ANIP 393.1K
  • Earning Date
  • DNOW 05-07-2025
  • ANIP 05-09-2025
  • Dividend Yield
  • DNOW N/A
  • ANIP N/A
  • EPS Growth
  • DNOW N/A
  • ANIP N/A
  • EPS
  • DNOW 0.75
  • ANIP N/A
  • Revenue
  • DNOW $2,409,000,000.00
  • ANIP $674,068,000.00
  • Revenue This Year
  • DNOW $6.66
  • ANIP $27.68
  • Revenue Next Year
  • DNOW $4.35
  • ANIP $7.74
  • P/E Ratio
  • DNOW $19.39
  • ANIP N/A
  • Revenue Growth
  • DNOW 4.74
  • ANIP 30.27
  • 52 Week Low
  • DNOW $11.42
  • ANIP $52.50
  • 52 Week High
  • DNOW $18.45
  • ANIP $73.72
  • Technical
  • Relative Strength Index (RSI)
  • DNOW 39.15
  • ANIP 42.24
  • Support Level
  • DNOW $13.86
  • ANIP $68.50
  • Resistance Level
  • DNOW $16.64
  • ANIP $73.72
  • Average True Range (ATR)
  • DNOW 0.58
  • ANIP 2.96
  • MACD
  • DNOW -0.15
  • ANIP -0.43
  • Stochastic Oscillator
  • DNOW 27.16
  • ANIP 3.08

About DNOW NOW Inc.

Dnow Inc is a company engaged in world-wide supplying of energy and industrial products and packaged, engineered process and production equipment with a legacy of over one sixty years. It offers a broad set of supply chain solutions combined with a suite of digital solutions branded as DigitalNOW that provide customers world-class technology for digital commerce, data and information management. Its locations provide products and solutions to exploration and production companies, midstream transmission and storage companies, refineries, chemical companies, utilities, mining, municipal water, manufacturers, engineering and construction companies. The Company has three reportable segments being United States, Canada and International.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: